SCHEMBL8874693

SCHEMBL8874693

CC1C(=O)CCc2cccc(Br)c21

nearest known ligand 0.42

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PDE7A Q13946 1/20 0.35
PDE7B Q9NP56 1/20 0.35
CYP2A6 P11509 1/20 0.34
HTR2C P28335 1/20 0.32
BRD4 O60885 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9341290 0.79 HTR2C (0.49) CYP2A6HTR2C
SCHEMBL9052842 0.76 DRD2 (0.45)
SCHEMBL4650091 0.72 HTR2C (0.38) HTR2C
SCHEMBL7918368 0.71 GID4 (0.41) BRD4
SCHEMBL31383852 0.71 RAB9A (0.32) HTR2C
SCHEMBL7238842 0.71 ALDH1A1 (0.38) PDE7APDE7B
SCHEMBL29428654 0.70 PDE7A (0.39) PDE7APDE7B
SCHEMBL13198514 0.70 PDE7A (0.39) PDE7APDE7B
SCHEMBL8876396 0.70 DRD2 (0.32)
SCHEMBL8876400 0.70 DRD2 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1051990-C Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and 3-aminochromones LILLY CO ELI (US) 2000-05-03 CN disclosed
US-5637624-A ANTISEROTONIN AGENT ELI LILLY AND COMPANY (US) 1997-06-10 US disclosed
US-5594034-A ADMINISTERING DIRECT ACTING 5-HYDROXYTRYPTAMINE AGONIST TO MAMMAL ELI LILLY AND COMPANY (US) 1997-01-14 US disclosed
US-5594025-A Method of inhibiting gastric acid secretion with 5-substituted-3-aminochromane ELI LILLY AND COMPANY (US) 1997-01-14 US disclosed
EP-0455510-B1 Use of 5-HT1A receptor agonist compounds for inhibiting gastric acid secretion LILLY CO ELI (US) 1996-11-27 EP disclosed
US-5576352-A Method of inhibiting gastric acid secretion with aryloxypropanolamines ELI LILLY AND COMPANY (US) 1996-11-19 US disclosed
CN-1120532-A Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and 3-aminochromones LILLY CO ELI (US) 1996-04-17 CN disclosed
CN-1031262-C Ring-substituted 2-amino-1, 2, 3, 4-tetrahydronaphthalenes and 3-aminochromanes LILLY CO ELI (US) 1996-03-13 CN disclosed
US-5457120-A Antisecretory and antiserotonine agents ELI LILLY AND COMPANY (US) 1995-10-10 US disclosed
EP-0385658-B1 Ring-substituted 2-amino 1,2,3,4-tetra-hydronaphthalenes and 3-aminochromanes LILLY CO ELI (US) 1994-12-28 EP disclosed
US-5340838-A Administering serotonin agonist to mammals ELI LILLY AND COMPANY (US) 1994-08-23 US disclosed
US-5258379-A ADMINISTERING IN AN EFFECTIVE DOSAGE TO MAMMALS ELI LILLY AND COMPANY (US) 1993-11-02 US disclosed
US-5158956-A Administering serotonin receptor agonist ELI LILLY AND COMPANY (US) 1992-10-27 US disclosed
US-5096908-A 5-HT1A agonist ELI LILLY AND COMPANY (US) 1992-03-17 US disclosed
EP-0455510-A2 Use of 5-HT1A receptor agonist compounds for inhibiting gastric acid secretion ELI LILLY AND COMPANY (US) 1991-11-06 EP disclosed
EP-0385658-A1 Ring-substituted 2-amino 1,2,3,4-tetra-hydronaphthalenes and 3-aminochromanes ELI LILLY AND COMPANY (US) 1990-09-05 EP disclosed
CN-1045099-A Ring-substituted 2-amino-1, 2, 3, 4-tetrahydronaphthalenes and 3-aminochromanes LILLY CO ELI (US) 1990-09-05 CN disclosed